STACY WILSON: Open Payments
NPI 1982000568 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 66 payments from 14 companies in 2025. Trend: 2023 $298 · 2024 $539 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $294 |
| Madrigal Pharmaceuticals | 10 | $207 |
| Janssen Biotech, Inc. | 8 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $145 |
| Ardelyx, Inc. | 5 | $95 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: RINVOQ, REZDIFFRA, TREMFYA, IBSRELA, ENTYVIO, EOHILIA, XIFAXAN, DUPIXENT.
Industry payments across IN — which companies pay providers there.
